펩티드 합성 시장(2026-2030년)

The global peptide synthesis market is forecasted to grow by USD 545.6 mn during 2025-2030, accelerating at a CAGR of 8.7% during the forecast period. The report on the global peptide synthesis market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by industrialization of oral delivery systems and bioavailability optimization, strategic mainstreaming of ai-enhanced in-silico peptide discovery, structural expansion of cdmo capacity and automated solid-phase synthesis.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global peptide synthesis market is segmented as below:

By Product

• Consumables
• Equipment
• Services

By Technique

• Chemical
• Biological

By Application

• Therapeutic
• Diagnostic
• Research

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Switzerland
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the integration of automated continuous flow synthesis and high-throughput assembly as one of the prime reasons driving the global peptide synthesis market growth during the next few years. Also, growth of green chemistry mandates and sustainable solvent recovery architectures and proliferation of personalized neoantigen and precision oncology peptide modalities will lead to sizable demand in the market.

The report on the global peptide synthesis market covers the following areas:

• Global peptide synthesis market sizing
• Global peptide synthesis market forecast
• Global peptide synthesis market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global peptide synthesis market vendors that include Agilent Technologies Inc., AmbioPharm Inc., AnaSpec Inc., Bachem AG, Bio Synthesis Inc, Biomatik Corp., Biosynth Ltd., CEM Corp., ChinaPeptides Co. Ltd., Corden Pharma Intl. GmbH, CPC Scientific Inc., GenScript Biotech Corp., GL Biochem, JPT Peptide Technologies GmbH, LifeTein LLC., PolyPeptide Group, Proteo Genix, RS Synthesis, Sigma Aldrich Chemicals Ltd., Thermo Fisher Scientific Inc.. Also, the global peptide synthesis market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Technique
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Peptide Synthesis Market 2020 - 2024
  • Historic Market Size - Data Table on Global Peptide Synthesis Market 2020 - 2024 ($ million)
• 5.2 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.3 Technique segment analysis 2020 - 2024
  • Historic Market Size - Technique Segment 2020 - 2024 ($ million)
• 5.4 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI in global peptide synthesis market
• 6.2 Impact of geopolitical conflict for global peptide synthesis market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Product

• 8.1 Market segments
• 8.2 Comparison by Product
• 8.3 Consumables - Market size and forecast 2025-2030
• 8.4 Equipment - Market size and forecast 2025-2030
• 8.5 Services - Market size and forecast 2025-2030
• 8.6 Market opportunity by Product
  • Market opportunity by Product ($ million)

9 Market Segmentation by Technique

• 9.1 Market segments
• 9.2 Comparison by Technique
• 9.3 Chemical - Market size and forecast 2025-2030
• 9.4 Biological - Market size and forecast 2025-2030
• 9.5 Market opportunity by Technique
  • Market opportunity by Technique ($ million)

10 Market Segmentation by Application

• 10.1 Market segments
• 10.2 Comparison by Application
• 10.3 Therapeutic - Market size and forecast 2025-2030
• 10.4 Diagnostic - Market size and forecast 2025-2030
• 10.5 Research - Market size and forecast 2025-2030
• 10.6 Market opportunity by Application
  • Market opportunity by Application ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 Switzerland - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 India - Market size and forecast 2025-2030
  • 12.5.2 China - Market size and forecast 2025-2030
  • 12.5.3 Japan - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Singapore - Market size and forecast 2025-2030
  • 12.5.6 Indonesia - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 South Africa - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 Israel - Market size and forecast 2025-2030
  • 12.6.7 Turkey - Market size and forecast 2025-2030
  • 12.6.8 Chile - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Industrialization of oral delivery systems and bioavailability optimization
  • Strategic mainstreaming of AI-enhanced in-silico peptide discovery
  • Structural expansion of CDMO capacity and automated solid-phase synthesis
• 13.2 Market challenges
  • Intensification of environmental sustainability mandates and solvent waste management
  • Persistence of manufacturing scalability constraints and structural capacity bottlenecks
  • Technical debt of achieving purity standards and specialized labor scarcity
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Integration of automated continuous flow synthesis and high-throughput assembly
  • Growth of green chemistry mandates and sustainable solvent recovery architectures
  • Proliferation of personalized neoantigen and precision oncology peptide modalities

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Agilent Technologies Inc.
  • Agilent Technologies Inc. - Overview
  • Agilent Technologies Inc. - Business segments
  • Agilent Technologies Inc. - Key news
  • Agilent Technologies Inc. - Key offerings
  • Agilent Technologies Inc. - Segment focus
  • SWOT
• 15.5 AmbioPharm Inc.
  • AmbioPharm Inc. - Overview
  • AmbioPharm Inc. - Product / Service
  • AmbioPharm Inc. - Key offerings
  • SWOT
• 15.6 AnaSpec Inc.
  • AnaSpec Inc. - Overview
  • AnaSpec Inc. - Product / Service
  • AnaSpec Inc. - Key offerings
  • SWOT
• 15.7 Bio Synthesis Inc
  • Bio Synthesis Inc - Overview
  • Bio Synthesis Inc - Product / Service
  • Bio Synthesis Inc - Key offerings
  • SWOT
• 15.8 Biomatik Corp.
  • Biomatik Corp. - Overview
  • Biomatik Corp. - Product / Service
  • Biomatik Corp. - Key offerings
  • SWOT
• 15.9 CEM Corp.
  • CEM Corp. - Overview
  • CEM Corp. - Product / Service
  • CEM Corp. - Key offerings
  • SWOT
• 15.10 ChinaPeptides Co. Ltd.
  • ChinaPeptides Co. Ltd. - Overview
  • ChinaPeptides Co. Ltd. - Product / Service
  • ChinaPeptides Co. Ltd. - Key offerings
  • SWOT
• 15.11 Corden Pharma Intl. GmbH
  • Corden Pharma Intl. GmbH - Overview
  • Corden Pharma Intl. GmbH - Product / Service
  • Corden Pharma Intl. GmbH - Key offerings
  • SWOT
• 15.12 GenScript Biotech Corp.
  • GenScript Biotech Corp. - Overview
  • GenScript Biotech Corp. - Business segments
  • GenScript Biotech Corp. - Key offerings
  • GenScript Biotech Corp. - Segment focus
  • SWOT
• 15.13 JPT Peptide Technologies GmbH
  • JPT Peptide Technologies GmbH - Overview
  • JPT Peptide Technologies GmbH - Product / Service
  • JPT Peptide Technologies GmbH - Key offerings
  • SWOT
• 15.14 PolyPeptide Group
  • PolyPeptide Group - Overview
  • PolyPeptide Group - Product / Service
  • PolyPeptide Group - Key offerings
  • SWOT
• 15.15 Proteo Genix
  • Proteo Genix - Overview
  • Proteo Genix - Product / Service
  • Proteo Genix - Key offerings
  • SWOT
• 15.16 RS Synthesis
  • RS Synthesis - Overview
  • RS Synthesis - Product / Service
  • RS Synthesis - Key offerings
  • SWOT
• 15.17 Sigma Aldrich Chemicals Ltd.
  • Sigma Aldrich Chemicals Ltd. - Overview
  • Sigma Aldrich Chemicals Ltd. - Product / Service
  • Sigma Aldrich Chemicals Ltd. - Key offerings
  • SWOT
• 15.18 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations